1 – 10 of 527
- show: 10
- |
- sort: year (new to old)
- |
- Export
- 2023
- Neonatal magnesium levels are safe after maternal MgSO4 administration : a comparison between unexposed preterm neonates and neonates exposed for fetal neuroprotection or maternal eclampsia prevention-a cohort study (vol 181, pg 2971, 2022) (2023) EUROPEAN JOURNAL OF PEDIATRICS. 182.
- Preterm birth during the COVID-19 pandemic : more, less, or just the same? (2023) ACTA CLINICA BELGICA. 78(2). p.140-159
- Wanneer is induceren in een ongecompliceerde zwangerschap geïndiceerd? (2023) TIJDSCHRIFT VOOR VROEDVROUWEN. 29(1). p.6-12
- Pregnancy termination at a viable stage in daily clinical practice : a nationwide mortality follow‐back study in Flanders, Belgium (2023) PRENATAL DIAGNOSIS. 43(6). p.781-791
- Components of perinatal palliative care : an integrative review (2023) CHILDREN-BASEL. 10(3).
- Effect of biphasic CAPA-IVM on ovarian tissue oocytes of transgender men (2023) HUMAN REPRODUCTION. In Human Reproduction 38(Supplement 1). p.i396-i397
- Characterization of ovarian tissue oocytes from transgender men reveals poor calcium release and embryo development, which might be overcome by spindle transfer (2023) HUMAN REPRODUCTION. 38(6). p.1135-1150
- Factors related to police reporting in sexual assault care centers : are we underestimating the role of support persons? (2023) VIOLENCE AGAINST WOMEN.
- Generation of human induced pluripotent stem cell line UGENTi001-A from a patient with Marfan syndrome carrying a heterozygous c.7754 T > C variant in FBN1 and the isogenic control UGENT001-A-1 using CRISPR/Cas9 editing (2023) STEM CELL RESEARCH. 67.
- Generation of human induced pluripotent stem cell line UGENTi001-A from a patient with Marfan syndrome carrying a heterozygous c.7754 T >C variant in FBN1 and the isogenic control UGENT001-A-1 using CRISPR/Cas9 editing (2023) STEM CELL RESEARCH. 67.